Canada markets closed

Ceapro Inc. (CZO.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.2700-0.0200 (-6.90%)
At close: 03:49PM EDT

Ceapro Inc.

7824 – 51 Avenue NW
Edmonton, AB T6E 6W2

Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Gilles R. Gagnon ICD.D, M.B.A., M.Sc.CEO, President & Director560kN/A1954
Ms. Stacy Prefontaine C.A., CPA, CA, CPACFO & Corporate Secretary232.99kN/AN/A
Dr. Bernhard SeifriedSenior Director of Research & TechnologyN/AN/AN/A
Mr. Michel Regnier P. Eng.Senior Vice President of Technical OperationsN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.


Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries. It also offers natural active ingredients, including oat powder, oat oil, oat peptides, and lupin peptides to the personal care, cosmetic, medical, and animal health industries; anti-aging skincare products to the cosmeceutical industries; and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner. The company has a research collaboration with the Angiogenesis Foundation. The company was incorporated in 1997 and is headquartered in Edmonton, Canada.

Corporate Governance

Ceapro Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.